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Enterotoxigenic Escherichia coli (ETEC) are one of common pathogens causing 
diarrhoea in people worldwide. This bacterium is affecting mainly young children 
in developing countries and travellers to such destinations causing deaths and trav-
eller’s diarrhoea for them, respectively. The frequently isolated ETEC strains from 
patients have an immunogenic surface protein colonization factor (CS6). This sur-
face antigen (CS6) is helping in adhesion to the host small intestinal epithelium 
enabling ETEC to produce the heat-labile (LT) and/ or heat-stable (ST) enterotoxin. 
The CS6 is expressed as typical bacterial operon that contains four genes (cssA-
BCD) and transcribed once. The cssA and cssB encode for the structural subunits; 
cssC and cssD encode for chaperone and usher proteins, respectively. In order to 
make a preventive, treatment or vaccine strategy, more information is needed to be 
known about these genes expression and their surface assembly to form coloniza-
tion factor and its role in attachment to the host intestinal epithelium. 
The aim of this study is to express and purify the four possible structural subu-
nits; CssA_dscA (AA), CssA_dscB (AB), CssB_dscB (BB) and CssB_dscA (BA) 
in order to determine their surface assembly and their stability functions. Future 
goals can be solving the 3D structures and designing candidate vaccines and/or 
treatments against ETEC. Methods used for this work include cloning of four pos-
sible structural subunits, protein expression tests, and protein purification by ion 
exchange and size exclusion chromatographic techniques and stability studies using 
CD (Circular Dichroism) spectroscopy.  
In conclusion, the Donor strand complementation (DSC) theory was successful 
to predict candidate fimbrial structures that were purified and studied chemically 
and thermally in this work. The four subunits (AA, AB, BB and BA) were success-
fully cloned then protein expressed and purified using liquid chromatography tech-
niques. Thermal and chemical studies showed that hetero-polymerized subunits, 
(AB and BA) were more stable against chemical and thermal denaturation com-
pared to the homo-polymerized subunits (AA and BB). Subunit BA and AB were 
the most stable among the 4 subunits. These results favour the formation of hetero-
polymerized subunits (AB and BA) more than the homo-polymerized ones. Further 
studies are needed to get better understanding of the mechanism of ETEC attach-
ment to the host intestinal cells. These studies would need to get protein crystals 
then solving their structure in order to improve the chance of finding better treat-
ment and successful vaccination method. 
Keywords: ETEC, CS6, LT, ST, DSC, CD.   
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1.1 Background 
Enterotoxigenic Escherichia coli (ETEC) is one of the most important causative 
organisms of diarrhoea between people worldwide (Jiang, Lowe et al. 2002; Rao, 
Wierzba et al. 2005; Tobias, Holmgren et al. 2010). It is characterized by high 
morbidity and mortality among infants and children less than five years old in the 
developing countries (Tobias, Holmgren et al. 2010). About 1.5 million deaths 
occur per year due to acute infectious diarrhoea for children of developing world 
caused mainly by ETEC, rotavirus, Vibrio cholera, and Shigella spp (Qadri, Sven-
nerholm et al. 2005). ETEC is regarded as the second most common cause of diar-
rhoea after retrovirus in children under 5 years old (Rivera, Ochoa et al. 2010), 
which causes about 400,000 deaths among infants and young children, and about 
7.5 million cases of gastroenteritis worldwide per year (Guerena-Burgueno, Hall et 
al. 2002; Gupta, Keck et al. 2008). In addition to the life threatening and death of 
infants worldwide, the predisposing to ETEC infection as a single pathogen for 
children for one or more times in the childhood period, will cause malnutrition and 
growth stunted by 2 years of age when compared with those children of no ETEC 
infection (Qadri, Saha et al. 2007). 
Adult visitors and tourists from North America and Europe to the endemic 
areas of the developing countries are often affected with the traveller’s diarrhoea 
caused mainly by ETEC (25% - 45%) and carry back the pathogen to their home 
lands (Jiang, Lowe et al. 2002; Qadri, Svennerholm et al. 2005; Cohen 2010). 
Military persons who travel to and reside in these countries are facing the same 
problem  (Cohen 2010). For example, 57% of the American troops settled in 
Middle East during 1990 to 1991 suffered from diarrhoea and about 20% of the 
units that settled in Saudi Arabia lost their duty due to sickness, meanwhile ETEC 
and Shigella were the major causative agents (Guerena-Burgueno, Hall et al. 
1 Introduction 
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2002). Diarrheal is the most challenging medical problem facing the military units 
that travel to such endemic regions, where ETEC is the most common causative 
agent (Cohen 2010).  
1.2 Role of Environment and Social factors 
ETEC remains endemic around the year but shows highest activity during warm 
seasons, which reflect the seasonality of the ETEC outbreaks and infections. This 
seasonality suggests that the tourists and travellers are more susceptible to illness 
during these times (Qadri, Svennerholm et al. 2005). Different phenotypes of 
ETEC are found according to the different geographical areas, for example the ST-
only ETEC was more isolated from Kenya and represented 51% (Shaheen, Kamal 
et al. 2003) of the studied clinical cases, LT-only ETEC was most common in 
Jamaica with 58%, (Jiang, Lowe et al. 2002) and the, LT/ST ETEC was the 
predominant cases in India that represented about 45% (Jiang, Lowe et al. 2002) of  
the studied cases. 
1.3 Risk factors of ETEC infections 
The main source for infection with ETEC is the faecal-oral route from contaminat-
ed food, water and beverages due to poor hygienic conditions (Yates 2005). For 
example the contaminated hands of food handlers or contaminated drinking water 
and food resources. Regions of rapid population growth especially in the suburban 
regions served with poor quality water, poor infrastructure facilities and lack of 
sewage systems will increase the risk factors of ETEC infections (Gupta, Keck et 
al. 2008). Some environmental events can also enhance the risk and the epidemi-
ology of ETEC; for example, during floods in Bangladesh the ETEC was a major 
cause of epidemic diarrhoea (Abu-Elyazeed, Wierzba et al.1999). In addition, 
serving of the water and weaning food to infants of about 3 months of age is re-
ported to cause ETEC infection (Gupta, Keck et al. 2008). 
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1.4 Bacteriology 
1.4.1 Classification and serotypes 
Enterotoxigenic Escherichia coli (ETEC) belongs to the Enterobacteriaceae fami-
ly, which is mostly Gram-negative, non-spore-forming, motile, lactose fermenta-
tive rod shaped organisms. ETEC can be classified further according to the sero-
type group like; O serotype (lipopolysaccharide antigen), H serotype (represent the 
flagellar antigen) and K serotype (capsular antigen) (Gupta, Keck et al. 2008).  
1.4.2  Virulence factors and CFs – binding sites and their effect  
In order to induce the disease, the ETEC strains should attach or colonize the small 
intestine mucosa after being ingested by individuals. This attachment to the host 
enteric epithelial cells is facilitated by the presence of surface antigens called col-
onization factor antigens (CFAs), coli surface antigens (CSs), or putative coloniza-
tion factors (PCFs). These factors are mostly immunogenic proteins that bind to 
receptors on the host intestinal mucosa. Most of the CFs are fimbrial or fibrillar 
proteins, while some are not fimbrial in structure, for example CFA/I is a fimbrial 
antigen whereas CFA/II and CFA/IV consist of a wide variety of antigens (Tobias, 
Lebens et al. 2008; Rivera, Ochoa et al. 2010).  
 Up to date, more than 25 human colonization factors (CFs) are known for 
ETEC. The major CFs where frequently seen recently in clinical isolates were the 
CFA/I, CS3 and CS6 (Guerena-Burgueno, Hall et al. 2002). The CS6 antigen is 
taking up growing interest since it is isolated from clinical specimens from many 
countries and frequently seen worldwide (Byrd and Cassels 2003; Ghosal, 
Bhowmick et al. 2009; Rivera, Ochoa et al. 2010). Other main virulence factors 
for ETEC that causes secretory diarrhoea in the affected persons are the produc-
tion of heat-labile enterotoxin (LT) and/or heat-stable (ST) enterotoxin that secret-
ed after adhesion to the host intestinal mucosa by the help of CFs (Qadri, Saha et 
al. 2007). 
LT enterotoxin is an immunogenic protein multimer encoded by the eltA and 
eltB genes, and consists of one A subunit surrounded by five identical B subunits. 
The A subunit is responsible for the catalytic activity (enzymatic) of the toxin, 
while the B subunits are responsible for the irreversible binding activity to the host 
mucosal cells surfaces gangliosides GM1 and GD1b. LT toxin resembles cholera 
toxin in many aspects like structure, physiology and mode of action or pathogene-
sis process. The A subunits stimulate the cyclic AMP (cAMP) and increase its 
production by binding to intracellular adenylyl cyclase. The other heat-stable (ST) 
14 
enterotoxin is non-immunogenic small peptide encoded by two genes: estA and 
st1, that produce STh and STp, respectively. The STh is isolated from human and 
the STp is isolated from pigs. STh binds to and activates the membrane guanylate 
cyclase resulting in increased intracellular cGMP while STp increases the cyto-
solic Ca2+ concentration and activates the release of prostaglandin E2 and seroto-
nin. The increase and activation of both cAMP and cGMP induced by LT and ST 
enterotoxin, respectively, lead to increased chloride secretion and ions from the 
crypt cells and impairment of the absorption of sodium chloride pump causing 
watery diarrhoea (Sears and Kaper 1996; Kaper, Nataro et al. 2004).  
1.5 Clinical Feature  
Most clinical cases of diarrhoea caused by ETEC can occur early after eight hours 
from the infection and last about four days without treatment (self-limited), while 
symptoms vary from mild to severe (Rivera, Ochoa et al. 2010). The onset of ill-
ness can be varied, shorter or longer (Gupta, Keck et al. 2008). The symptoms of 
the illness range from mild to severe. The common feature of this illness is charac-
terized by the sudden onset of acute watery diarrhoea that can be accompanied by 
vomiting and abdominal cramps. Dehydration, dry mouth, rapid pulse and de-
creased blood pressure occur in severe cases when large volumes of body fluids 
and electrolytes are lost in the stool, which can develop to shock. Fever and 
bloody stool are usually not seen. When hydration is administrated, the patient will 
survive without any sequels (Qadri, Svennerholm et al. 2005; Gupta, Keck et al. 
2008; Rivera, Ochoa et al. 2010). 
The pathophysiology of the ETEC infection resembles the disease caused by 
Vibrio cholera (causes cholera disease) and the symptoms are usually identical 
especially in adult patients. The secretory diarrhoea is formed after secretion of the 
(LT) and/or (ST) in the intestinal lumen that leads to increased chloride secretion 
from the enterocytes and thus increasing osmotic pressure in the gut lumen. The 
result is accumulation of large volume of fluids that will be secreted out from the 
body into the stool causing progressive and large amounts of fluids and electrolyte 
loss. 
1.6 Prevention and Vaccination 
Food supplementation with zinc for infants and children less than 5 years old will 
help to protect them from the malnutrition and enhance their ability to resist the 
ETEC infection and other enteric pathogens such as cholera and Shigella by stimu-
lating adaptive immune response (Albert, Qadri et al. 2003). Other important fac-
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tor is the breast feeding that can reduce the ETEC diarrhoea and mortality in the 
infants(Giugliani and Victoria 2000).Maternal milk contains secretory immuno-
globulin (Ig A) antibodies and anti-inflammatory factors. But the breast milk is 
regarded limited factor since when stopped and after weaning there will be a high-
er risk for infection since the transferred maternal immunity is stopped (Qadri, 
Svennerholm et al. 2005). The behavioural and social factors will exaggerate these 
risk factors of infection by supporting the weaned infants with contaminated food 
or water. For example in Mexico, people used to give a barley drink to infants 
about 3 months of age which increases the incidence of infectious diarrhoea 
caused by ETEC (Long, Wood et al. 1994). Personal hygiene is regarded more 
important protective factor against ETEC diarrhoea in Egypt (Abu-Elyazeed, 
Wierzba et al. 1999). 
1.7 CS6 gene of ETEC 
CS6 is one of the most frequently isolated antigens from clinical samples in vari-
ous parts of the world and getting higher attention in research and study regarding 
the pathogenesis process of ETEC (Nicklasson, Sjoling et al. 2008). CS6 antigen 
belongs to unique antigen group that is non-fimbrial in structure. The genes be-
longing to the CS6 follow a typical bacterial operon structure, which consists of 
four genes CssA, CssB, CssC and CssD, which is expressed and transcribed as a 
single message in low amounts and transported to the cell surface chaperon-usher 
pathway (Tobias, Lebens et al. 2008; Sabui, Ghosal et al. 2010).  
The CssA and CssB genes are encoding for two main heterologous structural 
subunits CssA and CssB, respectively. The CssC gene encodes for the chaperone 
protein, and finally the CssD gene encodes for the usher protein. The chaperon 
protein (CssC) is assumed to be responsible for folding of the structural subunits 
(CssA and CssB) and help in their protection from enzymatic proteolysis in 
periplasm. The usher protein (CssD) transports the structural subunits (CssA and 
CssB) from chaperon across the cell membrane to the cell surface (Ghosal, 
Bhowmick et al. 2009; Jansson, Tobias et al. 2009). The production of two 
subunits CssA and CssB is assumed to be 1:1 that means equal amounts are 
produced of these both subunits concurrently according to previous study (Ghosal, 
Bhowmick et al. 2009)  
It is now established that the CS6-expressing ETEC binds to human small in-
testine epithelial cells through the binding of CssA subunit to the extracellular 
protein matrix, fibronectin (Fn) in CFU-dependent saturable manner. And the abil-
ity of CS6 to bind to glycosphingolipid as adhesion receptors is achieved through 
the CssB subunit which have a highly specific binding capacity to the Sulfatide 
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(SO3-3Galb1Cer), the main acid glycosphingolipid of the human small intestinal 
epithelial cells (Jansson, Tobias et al. 2009; Sabui, Ghosal et al. 2010). The immu-
nologic characteristic of the structural subunits of CS6 gene to induce immunity is 
analysed and found that the purified CssA subunit have a poor immunogenic abil-
ity, while the CssB subunit is found to be highly immunogenic (Ghosal, 
Bhowmick et al. 2009). 
1.8 Chaperone/usher pathway and Donor strand 
complementation theory 
Chaperone/usher pathway is one major method for the assembly of the adhesive 
organelles of gram-negative bacteria, Enterobacteriaceae family. It is a simple 
mechanism that has only two specific proteins, a periplasmic chaperone and an 
usher protein used for assembly and transportation of the folded subunits (Zavi-
alov, Batchikova et al. 2001; Zavialov, Kersley et al. 2002; Zavialov, Zav'yalova 
et al. 2007). 
There are two families of the periplasmic chaperones classified according to 
sequence analysis, the FGS and FGL. FGS chaperones have short F1-G1 loop, 
which are used mainly for rigid pili assembly, while FGL chaperones have long 
F1-G1 loop and are mainly dedicated for assembly of non-pilus (fimbrial) orga-
nelles (Zavialov, Zav'yalova et al. 2007; Zavialov and Knight 2007). The 
periplasmic chaperones roles are to help protecting the formed periplasmic subu-
nits by stable binding and avoiding the subunits from unwanted polymerization 
and proteolytic enzymes by covering their assembly surfaces. The final role of the 
periplasmic chaperones is to transport the subunits to the outer membrane molecu-
lar usher (Zavialov, Kersley et al. 2002; Remaut and Waksman 2004; Zavialov 
and Knight 2007). The outer membrane molecular usher acts by releasing the sub-
units from the chaperone and help in their assembly or polymerization. Finally, 
molecular usher transports the formed fibres to the cell surface (Zavala, Zav'yalo-
va et al. 2007). 
1.9 Chaperone structure and interaction with subunits  
 The periplasmic chaperones are formed of two immunoglobulin-like (Ig-like) 
domains forming an L-shaped or boomerang-shaped, molecule (Remaut and 
Waksman 2004; Busch and Waksman 2012; Waksman and Hultgren 2009). The 
pilin or fimbriae have a hydrophobic cleft or groove on their surface due to their 
structure building, where they lack the seventh C-terminal ß-strand and thus form 
incomplete Ig-like structure. The chaperone–subunit attachment is done by 
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donating the G1 ß-strand of the chaperone to the pilin (fimbriae) hydrophobic 
groove to form a stable complex. This process in which the chaperone and subunit 
are attached to form the stable complex is called donor-strand complementation 
(DSC) (Remaut and Waksman 2004; Busch and Waksman).  
The pilin (fimbriae) subunits are attached to each other forming polymeriza-
tions occurs through Donor Strand Exchange mechanism (DSE). In this mecha-
nism the chaperone G1 donor ß-strand is replaced by N-terminal extension of the 
next subunit in assembly to form the polymer (Busch and Waksman 2012). 
The idea of this study is based on the donor strand complementation mecha-
nism (Zavialov, Batchikova et al. 2001; Zavialov, Kersley et al. 2002; Zavialov, 
Zav'yalova et al. 2007) where the structural subunits (here CssA and CssB) are 
assumed to be attached to each other’s similarly to their attachment within classi-
cal chaperone usher pathway through the usher G1 donor ß-strand, in which, the 
chaperone G1 donor ß-strand is replaced by N-terminal extension of the next sub-
unit in assembly (CssA and CssB) by the  DSE mechanism (Busch and Waksman 
2012). 
According to the DSC mechanism we will try to find the assembly pattern of 
the CssA and CssB based mainly on Caf1 project (Zavialov and Knight 2007). The 
schematic versions of the complemented subunits are shown in Figure 1 below. 
 
 
 
 
 
 Figure 1. Versions of complemented subunits 
We expect to have three possible polymers to be formed according to this study 
shown in Figure 2 below as following: Homo-polymerization of subunit A (M1), 
homo-polymerization of subunit B, (M2) and the hetero-polymerization of alter-
nating both subunit A and subunit B together (M3) 
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M1 M2 M3 
 
 
 
 
 
 
 
 
 
Figure 2. The possible polymers of this study. 
The aim of this study is to put a step forward revealing the structural assembly of 
the CS6 expressed proteins, which help more in understanding the pathogenesis, 
diagnosis and future treatment methods. Vaccination as well can be studied and 
developed as a preventive method against ETEC. 
Note: In this thesis 
• CssA_dscA is simplified to A-dscA or AA,   
• CssA_dscB is simplified to A-dscB or AB,  
• CssB_dscB, is simplified to B-dscB or BB,     
• CssB_dscA is simplified to B-dscA or BA.   
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2.1 Expression Plasmids Construction 
The genes of the four subunits (CssA_dscA, CssA_dscB, CssB_dscB, and 
CssB_dscA) were already prepared inside the vector (pUC57) by Invitrogen Co.  
The (pUC57) vector is surrounded by the EcoRI and SacI restriction sites, forming 
the PUC57-CssAA, PUC57-CssBB, PUC57-CssAB and PUC57-CssBA.  
For the Expression plasmid creation, the pET101D vector (Invitrogen) was 
used to create the pET-CssA_dscA, pET-CssB_dscB, pET-CssA_dscB and pET-
CssB_dscA. pET101D vector have the same restriction sites (the EcoRI and SacI) 
as in pUC57 vector. Required expression plasmids were made by ligation of the 
EcoRI- SacI fragments from pUC57 vectors that contain our required genes to the 
same location of EcoRI- SacI fragments in the pET101D vector. Our target genes 
were located downstream of the T7 promoter.  
Note: all the 4 subunits (AA, AB, BB, and BA) were treated the same in all the 
following methods in this work. 
2.1.1 Isolation of the (AA, BB, AB and BB) DNA fragments by PCR 
The four subunits genes were isolated using the PCR method, where the enzyme 
used was pfu Ultra DNA polymerase. All the ingredients of the PCR reaction in-
cluding reaction mix and PCR program used in this experiment are shown in Table 
1 and Table 2, respectively in the next page. 
 
 
 
2 Materials and methods 
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Table 1. PCR reaction mixture ingredients used for AA and BB fragment isolation 
Ingredients Composition in µl 
Sterile Water 19.5 
10x Pfu buffer 2.5 
dNTPs (10 mM) 0.5 
Forward primer (20 ρmol) 0.5 
Reverse primer (20 ρmol) 0.5 
Template DNA (10 ng/µl) 1.0 
Pfu Ultra enzyme 0.5 
Total reaction volume 25 µl 
Table 2. PCR program 
Steps Cycles Temperature and Time 
Initial Denaturation- window1 1 95°C for 1 min 
Denaturation- window 2 25 95°C for 1 min 
Annealing 25 52°C for 1 min 
Elongation 25 72°C for 8 min 
Final elongation –window 3 25 72°C for 10 min 
Hold in- window 4 1 4°C 
2.1.2 Agarose Gel Electrophoresis 
1% Agarose gel was prepared for analysing the resulting PCR product as follows: 
1 gram of pure Agarose (Invitrogen) powder was weighed in 500 ml bottle, then 
added 100 ml 1x TAE buffer and heated in microwave till melting of the Agarose, 
then cooled down to 50 °C. After that, 50 ml of the cooled Agarose gel was taken 
and added 4 µl GelRed (Biotium-USA) then mixed properly. The gel was then 
poured in the gel-casting tray. Fresh 1x TAE buffer then added to the tank to be 
used as running buffer. Sample volume was 60 µl that loaded to the gel by using 
50 µl PCR products and 10 µl 6x loading dye. DNA marker, 1000 bp, was loaded 
at the first well then the PCR products samples were loaded. Electrophoresis was 
run at 100 volts for 40-45 minutes. Finally, the gel was examined under the UV 
light shortly and photos were taken. 
2.1.3 DNA Purification from Agarose gel 
PCR products or DNA bands were cut carefully using clean scalpel under the UV 
lamp and gel slices were made small as possible. The purification was done using 
QlAquick Gel Extraction Kit Protocol (QIAGEN, USA) where the gel piece was 
weighed then added 3 volumes of buffer QG to one volume of the gel. Then the 
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mixture was incubated at 50 °C for 10 minutes with mixing each 2-3 minutes to 
dissolve the gel completely. Dissolved gel was then applied to the QIAquick spin 
column and centrifuged at 13,000 rpm for 1 minute to bind DNA, then the flow-
throw was discarded, after that washed by (0.75 ml) Buffer PE and centrifuged 
again for 1 minute at 13,000 rpm. Flow-throw was discarded and centrifuge ap-
plied again with the same previous conditions. DNA elution was done by adding 
50 µl Elution buffer (EB) to the centre of the column and centrifuged finally as 
before. 
2.1.4 Cloning and ligation into pET101/ TOPO vector 
This step was done for the construction of pET101-CssA_dscA, pET101-
CssB_dscB, pET101-CssA_dscB and pET101-CssB_dscA using the TOPO cloning 
reaction. TOPO Cloning Ligation reaction mixture was prepared by taking 1 µl of 
fresh purified DNA from the previous step, salt solution 1 µl, sterile water 3 µl, 
and 1 µl of TOPO vector (Invitrogen, USA). The reaction was mixed gently in 
eppendorf tube and incubated for 20 minutes at room temperature. 
Transformation of DH5α competent cells was done as follows: One vial of 
DH5α competent cells (Invitrogen, USA) were used per transformation reaction by 
thawing in ice for 5 minutes. Then 2 µl of the ligation mixture was added to the 
DH5α competent cells and incubated for 30 minutes inside ice. Then heat shock 
was applied by incubating the mixture directly in 42 °C water bath for 1 minute 
without shaking. Then removed back quickly and incubated again in ice for 5 
minutes. 400 µl of fresh LB medium then added to the vial and incubated at 37 °C 
for 1 hour and shaking of 200 rpm. Finally, 400 µl of the transformation reaction 
is plated on Pre-warmed LB agar plates containing certain antibiotic (ampicillin 
100µg/ ml) and spread well, and then the plates were inverted after absorption the 
solution and incubated at 37 °C overnight. 
2.1.5 Colony PCR 
This method was used for screening of positive transformation of the previous 
step. Some bacterial colonies were taken from the overnight culture from the LB 
agar plate and added to 4 ml LB broth containing appropriate antibiotic to our cell 
type (ampicillin 50µg/ ml), and incubated at 37 °C for about 3 hours under shaking 
at 200 rpm. Then 10 µl of the culture was incubated at 95 °C for 10 minutes using 
PCR heating block, then sample was immediately put in ice. This sample was our 
PCR template for the following Colony PCR. The Taq DNA polymerase primer 
(New England Bio lab, USA) and T7 forward primers used in this work. Table 3 
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and Table 4 show the Colony PCR mixture and Colony PCR program, respective-
ly. 
Table 3. PCR reaction mixture of Colony PCR 
Ingredients Composition in µl 
Sterile Water 19.8 
10x Taq buffer 2.5 
dNTPs (10 mM) 0.5 
Forward primer (20 ρmol) 0.5 
Reverse primer (20 ρmol) 0.5 
Template DNA (15 to 20 ηg/µl) 1.0 
Taq DNA polymerase 0.2 
Total reaction volume 25 
Table 4. Colony PCR program 
Steps Cycles Temperature and time 
Initial Denaturation- window1 1 94°C for 2 min 
Denaturation- window 2 25 94°C for 1 min 
Annealing 25 50°C for 1 min 
Elongation 25 72°C for 1 min 
Final elongation –window 3 1 72°C for 2 min 
Hold in- window 4 1 4°C 
2.2 Plasmid Purification  
The plasmid from the transformed cells that carries our insertion was purified us-
ing the QIAprep Spin MiniPrep Kit (QIGEN, USA). Firstly, about 600 µl of the 
overnight culture were put in a falcon tube of 15 ml size, centrifuged for 10 
minutes at 4500rpm.Then the supernatant was discarded and cell pellets were sus-
pended in 250 µl of the re-suspending buffer P1 and transferred to a microcentri-
fuge tube. After that 250 µl of P2 buffer was added and mixed thoroughly for 4-6 
times. Then 350 µl of neutralisation buffer N was added and mixed the same as 
before, then centrifuged for 10 minutes at 13,000 rpm in microcentrifuge.  
Supernatant was then transferred into QIAprep spin column and centrifuged for 
1 minute at 13,000 rpm again. Flow-through was discarded, followed by washing 
the column by adding 0.75 ml of the washing buffer (PE) and centrifuged for 1 
minute at 13,000 rpm. Flowthrough was discarded again and other centrifugation 
step was done as before to remove the residues of washing buffer. The QIAprep 
column is put in new clean microcentrifuge and the lid was cut, then the DNA was 
eluted by adding 50 µl of sterile water in the centre of the spin column, incubated 
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for 2 minutes then centrifuged for 1 minute. The solution was then tested by Nano 
drop and transferred to new eppendorf tube and the plasmids are stored at -20 °C. 
2.3 Glycerol stock preparation 
After finishing from colony PCR and be sure that the transformed cells gave posi-
tive colonies, a stock solution from these positively clones of transformed cells 
was prepared by adding 200 µl of sterile filtered 88 % glycerol to 600 µl of the 
overnight culture, both in eppendorf tube. The solution was then shaken by vortex 
for 10 seconds and instant freeze was applied using liquid Nitrogen. The final 
glycerol stock is stored at -80 °C. 
2.4 Transformation of plasmids into expression cells BL21-
DE3 
Purified plasmid from previous plasmid purification step was used to be trans-
formed into a homemade cell line (BL21-DE3) by heat shock method. Firstly the 
BL21-DE3 cells were taken from -80 °C and thawed in ice, and then 1 ul from 
purified plasmid was added, tapped and incubated for about 30 minutes on ice. 
After this, incubation in 42 °C water bath for 1 minute (as homemade cells) and 
transferred to ice for 5 minutes. Then 400 µl of LB medium was added and incu-
bated at 37 °C for 1 hour while shaking by 200 rpm. The cell culture then spread 
on the inverted pre-warmed agar plate overnight at 37 °C. 
2.5 Screen of clones by test expression 
This test was performed to test the expression of the positive clone of the BL21-
DE3 cells from previous transformation step. One positive single colony was taken 
and added to 5 ml LB medium containing ampicillin of 100 mg/ml. The culture 
was then grown overnight at 37 °C with shaking of 200 rpm. Next day inoculation 
was done by adding 4 ml of the overnight culture to a sterile 50 ml falcon tube 
containing 20 ml fresh LB medium with ampicillin (100 mg/ml). Culture was 
grown for 1 hour with shaking by 200rpm at 37 °C.  
Optical density was measured of the culture cells at wavelength of 600 nm to 
determine their density every hour, where the cells induction was carried out at 
density between 0.5 and 0.8 of cells. The main culture sample was divided into 2 
samples, 10 ml each. Cells induction was done by adding 20 ul IPTG (isopropyl ß-
D-1-thiogalactopyranoside) to get the final concentration of 1 mM to one sample 
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of 10 ml and incubated for 3-4 hours at 37 °C while the other 10 ml sample re-
mained not induced as negative control.  
2.6 Protein harvesting from periplasmic space 
Cell harvesting was done by taking 4 ml of both cultures separately, and then cen-
trifuged for 15 minutes at 4500 rpm, where cells present in the pellets. Supernatant 
was discarded and cell pellets were kept. Cell pellets were then re-suspended (dis-
solved) with 600 ul buffer containing (20 % w/v sucrose, 50 mM Tris-HCl pH. 
8.0, and 5 mM EDTA) and then transferred in microcentrifuge. Ratio of buffer to 
cells was 4 ml buffer/1 gram pellet. Then mixed and transferred to new eppendorf 
tube with proper labelling and incubated on ice for 10 minutes. Then centrifuga-
tion step was done at 5000 rpm for 15 minutes. Supernatant was collected and 
labelled as sucrose fraction and kept at -20 °C in cold room to be used for SDS 
PAGE analysis. 
 Cell pellets after centrifugation were suspended again with 200 ul of buffer (4 
ml/g) containing 5 mM MgSO4 and protease inhibitor, then kept incubated on ice 
for further 10 minutes and immediately centrifuged for 5 minutes at 10000 rpm. 
The clear supernatant was collected, representing the periplasmic fraction that 
was put in eppendorf tube with proper labelling and kept in -20 °C in cold room 
for further SDS PAGE and other analysis. 
2.7 SDS-PAGE (15%) for protein expression analysis 
Both stacking and separation SDS –PAGE gels were prepared according to Table 
5 below. 
Table 5. SDS PAGE ingredients for separation and stacking gels 
15% separating gel, pH 
8.8 ml 4% stacking gel, pH 6.8 ml 
88% Glycerol  0.525 H2O 1.84 
1M Tris-HCl, pH 8.8  1.87 1M Tris-HCl, pH 6.8 0.312 
30% AA-bis AA (30:1)  2.5 30% AA-bis AA (30:1) 0.325 
10% SDS       0.05 10% SDS 0.025 
10% PSA 0.05 10% PSA  (Acrylamide+Bis-acrylamide (29:1))       0.025 
TEMED         0.005 TEMED 0.002 
Total 5  2.5 
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Protein samples were prepared firstly by taking 30 ul of each sample in microcen-
trifuge tube then adding 10 ul of the 4x loading dye and 1 ul of β-mercapto-
ethanol (0.1 M) all in the same tube then boiled at 95 °C for 5 minutes. Meanwhile 
sample preparation, the gel was prepared by pouring separating gel and wait till 
solidified then some distilled water was added to make flat surface for about 1 cm 
below the well comb. Stacking gel was then poured and the comb was inserted 
directly to make the wells. When the stacking gel was polymerized, the comb was 
removed, samples were added to the wells and the running buffer was added. 
About 10 ul of the samples were added to wells and the low molecular weight 
ladder was loaded in the first lane. Electrophoresis was run at 200 V for 1 hour 
using 1x SDS Running buffer (25 mM Tris-base +192 mM Glycine + 0.1% SDS + 
H2O) or till the tracking dye reached to end. 
2.7.1 Gel staining with Coomassie Blue 
The gel was removed carefully from the casting glass and put in clean plastic box 
then added the fixation solution (30 % ethanol and 10 % acetic acid) over the gel, 
then heated near boiling using the microwave for about 10-15 seconds, then the 
fixation solution was removed and stored to be used again. The staining Coomass-
ie Blue solution was added to the gel, heated near boiling using microwave as 
before. Gel was then incubated within the Coomassie Blue solution for about 5 
minutes under shaking at room temperature. After that the gel was washed with 
distilled water, heated for about 2 minutes near boiling by microwave, and incu-
bated at room temperature for about 5 minutes or more under gentle shaking. Wa-
ter was changed and the rinsing of the gel with water was repeated till the gel 
background was low and the protein bands could be easily seen. Finally, the gel 
was scanned to reserve the results. 
2.8 Large culture and purification of protein 
This large culture technique was used to make overexpression of protein for the 
further purification steps. An overnight 4 litres large culture was prepared (4 flasks 
with 1litre each) by adding for each 1 litre 960 ml LB medium + 40 ml from the 
overnight AA,AB,BB, and BA cultures. 960 ul of ampicillin was added with con-
centration of (100mg/ml). Culture was then incubated for 2 hours and 15 minutes 
at 37 °C with shaking (large shaker incubator) at 145 rpm to reach an optical den-
sity (O.D) between 0.6 and 0.8. Measuring O.D was done followed by induction 
using (1 ml/L) of IPTG (1M).  
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Cultures were incubated again for protein expression for 3 hours at 37 °C with 
shaking at 145 rpm, and then centrifuged at 4200 rpm for 30 minutes using 1 litre 
plastic bottles. Cells were then suspended using 20 ml buffer containing 20% w/v 
sucrose, 50 Mm Tris-HCl pH 8.0 and 5 mM EDTA then kept on ice for 10 
minutes. Centrifugation was done for 20 minutes at 6800 rpm and the supernatant 
was saved in a separate container as the sucrose fraction to be analysed by SDS-
PAGE later. While cells pellets were re-suspended using 15ml of (5 mM) MgSO4 
and protease inhibitor (for osmotic shock) then kept on ice for 10 minutes, after 
that centrifuged for 20 minutes at 7500 rpm. The resulting supernatant is the 
periplasmic proteins that were collected for next dialysis step. 
2.9 Dialysis and filtration of protein 
Dialysis was done for protein samples in order to decrease the salt concentration 
(desalting) and for further buffer exchange techniques. The sample was put in a 
semipermeable dialysis membrane (SPECTRA/POR) and kept overnight inside the 
cold room. The dialysis buffer was selected according to the next used chromato-
graphic techniques, where the same loading buffer of the chromatography used as 
the dialysis buffer with the same pH. Table 6 below shows a list of dialysis buffers 
used for each subunit purification step. 
Table 6.  List of Dialysis buffer used 
Chromatography tech-
nique Dialysis Buffer used Elution Buffer used Used for purification of 
Anion Exchange- 
Source 30Q 
20 mM Tris-HCl pH 
7.4 
20mM Tris HCl + 1M NaCl 
pH 7.4 AA,AB,BB and BA 
Anion Exchange- 
Mono Q 20mM Bis-Tris  pH 6.0 
20mM Bis-Tris + 1M NaCl 
pH 6.0 BB and BA 
Cation Exchange- 
Mono S 
50 mM Sodium acetate 
pH 4.1 
50 mM NaAc+ 1M NaCl pH 
4.1 AA and AB 
Gel Filtration 20 mM HEPES, pH 7.3 20mM HEPES +150mM NaCl pH 7.3 AA,AB,BB and BA 
2.10 Protein purification by liquid chromatography 
The following chromatography techniques were used for protein sample purifica-
tion by using different columns by the automated system of ÄKTA Explorer, GE 
Healthcare, Sweden. 
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2.10.1  Anion-exchange chromatography (Source 30Q and MonoQ) 
Source 30Q chromatography is used as the first liquid chromatography purifica-
tion step for all the four subunits; AA, AB, BB, and BA. In this technique, the 
Source 30Q column was used as the first step of protein purification by anion-
exchange chromatography. The column was washed with three column volumes 
(CV) of the elution buffer (20 mM Tris-HCl, 1M NaCl , pH 7.4) then equilibrated 
with three CV of loading buffer (20 mM Tris-HCl, pH 7.4). The dialysed and fil-
tered protein samples were loaded at flow rate of 1 ml/ minute into the Source 30Q 
column. The column was then washed by using 1.5 CV of loading buffer to get the 
protein samples inside it. Elution step was done by using Elution buffer at a flow 
rate of 1 ml/ minute and gradient of 30% for 100 minutes. The SDS-PAGE analy-
sis was used after this step in order to identify the fractions of purified protein and 
mainly the peak and its related fractions. The protein sample was then put in dialy-
sis membrane again using proper dialysis buffer, the same as loading buffer for the 
next MonoQ chromatography technique. In this step the dialysis buffer was 20mM 
Bis-Tris pH 6.0. 
2.10.2 Mono Q chromatography (8 CV, 5MPa) 
Mono Q anion exchange chromatography was used as the second purification step 
for the subunits BB and BA only. Firstly, pump was washed at flow rate of 3 ml 
per minute, then column elution done with 5 CV where the elution buffer used was 
20 mM Bis-Tris, 1M NaCl, pH 6.0, then equilibrated with loading buffer of 20 
mM Bis-Tris, pH 6.0, as illustrated in Table 6 previously. Sample was then loaded 
and eluted using 4 CV at the same flow rate of 3 ml/minute with 1.5 ml fraction 
size. Then column was washed and equilibrated again. The resulted fractions of 
interest were run in SDS-PAGE. Protein samples were then concentrated using 
Vivaspin-6 column 5000 MWCO PES, GE Healthcare for the next uses in Gel 
Filtration step. 
2.10.3 Cation exchange chromatography (Mono S) 
Mono S column (1 ml) was used as Cation exchange chromatography second puri-
fication step for the subunits AA and AB only. The elution buffer used for wash-
ing was (50 mM Sodium acetate pH 4.1 +1 M sodium chloride) by 30 CV, then 
equilibrated by 30 CV of the loading buffer (50 mM Sodium acetate pH 4.1) with 
flow rate of 1 ml/min. Protein sample was loaded to the column in the same flow 
rate of 1 ml/min using 20 CV loading buffer then eluted at flow rate of 0.5 ml/min 
with fractions of 0.5 ml/tube. Gradient was 30 % for 30 minute for elution. The 
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SDS-PAGE analysis was used after this step and the protein samples then concen-
trated using Vivaspin-6 column 5000 MWCO PES (GE Healthcare). 
2.10.4 Size exclusion chromatography (Gel filtration) 
Gel filtration method was used to separate proteins of different sizes and can de-
termine their molecular weight. In our experiment here we used the Superdex 75E 
120 ml column (GE Health Care) to purify our proteins. The column was equili-
brated with 130 ml of 20 mM HEPES, pH 7.3, 150 mM NaCl. Flow rate was 1 
ml/minute. About 5.5 ml from Mono Q sample was concentrated to get approxi-
mately 1 ml (10.5 mg/ml) of concentrated sample. Elution rate was about 1 
ml/minute and the fraction size was 2 ml. After pure protein elution is finished the 
SDS-PAGE was run. 
2.11 Protein Stability study by Circular Dichroism (CD) 
Spectroscopy 
Circular Dichroism is used to study many aspects of protein structural properties, 
like the proteins behaviour and operations under certain conditions and other struc-
tural changes either by chemical denaturation or temperature, which are all im-
portant to understand their functions. The main uses of CD are to study the sec-
ondary structure of proteins, tertiary structure fingerprinting, and integrity of co-
factor binding sites. In CD Spectroscopy the difference between right and left cir-
cularly polarized light is measured as a function of wavelength. The far-UV bands 
(180-240 nm), which came mainly from peptide bond absorption, are reflecting the 
secondary structure of the protein like α-helix and β-sheet. While the near-UV 
bands (240-340 nm) of proteins are reflecting the tertiary structure of the protein, 
which derived mainly from peptide bonds absorption. 
2.11.1 Chemical denaturation using Guanidine Hydrochloride 
(GdnHCl)  
Different concentrations of GdnHCl were used to test the stability and unfolding 
of the four subunits (AA, AB, BB and BA) as shown in the Table 7 below. Protein 
subunits samples were diluted 4 times with 10 mM phosphate buffer, pH 7.0 and 
used different concentration of GdnHCl in buffer B solution. Samples were incu-
bated overnight (16-21 hours) at 21°C, then test was run. 
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Table 7. Reaction mix of GdnHCl and protein subunits by Circular Dichroism (CD) 
Sample S1 S2 S3 S4 S5 S6 S7 S8 S9 
GdnHCl in sample  (M ) 0 0.5 1 1.5 2 2.5 3 3.5 4 
Protein in 10 mM PB, pH 7.0  
(µl) 
100 100 100 100 100 100 100 100 100 
8M GdnHCl (µl) 0 12.5 25 37.5 50 62.5 75.0 87.5 100 
H2O  (µl) 100 87.5 75 62.5 50 37.5 25 12.5 0 
Total (µl) 200 200 200 200 200 200 200 200 200 
2.11.2 Thermal stability of the studied protein subunits  
Diluted protein samples were used in the absence of GdnHCl, to determine tem-
perature denaturation of the four subunits. Samples were heated from 30°C to 
90°C at a heating rate of 1°C per minute, and the resulted wavelength was record-
ed continuously. 
2.11.3 Free energy change ΔG (kJ/mol) calculation 
The free energy change ΔG (kJ/mol) calculation was done here depending on the 
thermal denaturing curves of the CD results. The ellipticity over a range of tem-
perature was normalized between 0-1 that gave the curve of a fraction (%) of pro-
tein in folded and unfolded state. This was done by using the following formula in 
Excel sheet: 
(Y) - Min (distribution)/ (Max (distribution)) - (Min (distribution)). 
Here, Y represents the folded and unfolded percentage value in the curve between 
0 and 1 depending upon the equation (ff ) + (fu) = 1. Where ff represents the total 
folded proteins and fu represent the total unfolded proteins. The results of these 
curves are shown in Figure 13 at page 43 (Creighton, 1997; Lee et al., 2005). 
  For calculating the Equilibrium Constant, Keq, the following equation is used          
K= fu /ff                                                                                            (1)                    
For fraction unfolded represented by the formula fu =(Yf-Y)/(Yf-Yu)     (2)           
And the fraction folded represented by the formula ff = Y-Yu/(Yf-Yu).               (3) 
Y is the observed value of protein folding at transitional state, fu is the unfolded 
protein value, and ff is the folded protein value. The Keq was calculated based on 
the points and data from the protein folding and unfolding percentage shown in 
Figure 13 in the Results section. For calculation used here, Y value was fixed for 
0.5 as representing the transitional state where about 50 % of the proteins are in 
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folded state and the others are unfolded. The fu and ff values were calculated by 
choosing two points at least at folded state for ff , and two points at unfolded state 
for fu. 
The free energy change, ΔG, is calculated using the following equation 
ΔG  RT ln K                                                                                               (4) 
Where R is the gas constant 8.314 (J /mol. K) and T is the absolute temperature 
in Kelvin and K is the calculated equilibrium constant (Creighton, 1997; Lee et al., 
2005).  
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3.1 Construction of Expression Plasmid for the four 
complemented subunits 
Required expression plasmids were constructed by ligation of the EcoRI-SacI 
fragments from pUC57 vectors, which contains our required genes, to the same 
location of EcoRI-SacI fragments in the pET101/TOPO vector. Figure 3 below 
shows the successful PCR results that confirmed the fragment isolation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. PCR results of 4 subunits isolation at 1 % Agarose gel: lane 1 represents the ladder 
(1000bp); lane 3, AA; lane 4, AB; lane 6, BB; and lane 7, BA. 
The four subunits genes were then isolated and ligated to pET101/TOPO vector 
and then transformed successfully to DH5α competent cells. After that, Colony 
PCR was conducted to confirm the positive transformation of the competent cells. 
Results are not shown here. 
3 Results and Discussion  
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3.2 Test expression results on SDS-PAGE 
Test expression was done for the four subunits in BL21-DE3 cells to enhance the 
protein expression conditions and to select the clones of higher expression poten-
tial. The SDS-PAGE analysis (Figure 4) shows that all subunits were successfully 
expressed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Test expression results on SDS-PAGE: lane 1, AB cells control; lane 2, AB cell (none 
induced); lane 3, AB cell (induced); lane 4, AB cell sucrose fraction; lane 5, AB old cell (none in-
duced); lane 6, AB cells (induced); lane 7, BA cells (none induced); lane 8, BA cells (induced); lane 
9, BA cells sucrose fraction; lane 10, BA old cells (none induced); lane 11, BA old cells (induced); 
lane 12, AA cells (induced); lane 13, BB cells (induced) and lane 14, control AB cells. 
Old samples, newly induced, and non-induced samples were run. The results 
shown in Figure 4 indicate that the induced samples were expressed successfully 
for all the 4 subunits. Lane 3 shows a successful expression of the AB subunits 
and lane 8 shows the expression of BA subunits. The AA subunits expression was 
shown in lane 12 and successful expression for the BB subunits, was shown in 
lane 13. Here we noticed that the AB and BA expression was stronger than BB 
and AA expression. 
Large cultures were done to get the overexpression of the protein successfully 
after the expression tests results. Then all the 4 subunits periplasmic proteins (AA, 
AB, BB and BA) were dialysed using the loading buffer of Source 30Q as an ani-
on-exchange chromatography using the 20mM Tris-HCl pH 7.4 
For the following protein purification steps, results to be shown will be for the 
two subunits BB and BA regarding protein purification. Other subunits AA and 
AB were purified in the same techniques except that MonoS was used as Cation-
12 1 2 3 4 5 6 7 8 9 14 11 10 13 
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exchange chromatography rather than MonoQ that was used for BB and BA 
subunits. 
3.3 Anion-exchange chromatography (Source 30 Q) results 
Results of Source 30Q (S30Q) chromatography are shown in Figure 5 for BB sub-
units, and in Figure 6 for BA subunits.  
Figure 5 shows the results for BB subunits. Figure 5A below shows the 
chromatogram of the Source 30Q purification at 280 nm absorbance and Figure 
5B in the following page shows the SDS gel run results of the fractions from the 
S30Q purification step. The Main Peak was located between fraction numbers 16 
and 22. Lane 5 in Figure 5B represents the main peak as our target protein fraction 
when compared to the Sucrose and Periplasmic fraction bands. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5A. Source30Q chromatography results for BB subunits: absorbance at 280 nm, and peak is 
between fraction numbers 16 and 22. 
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Figure 5B. SDS–PAGE results from peak fraction of the Source 30Q chromatography of BB subu-
nits: lane 1 is the Low molecular weight (LMW) marker; lane 2 is sucrose sample; lane 3 is 
periplasmic fraction; lane 4 is S30Q fraction 9; lane 5 is the S30Q fractions (18 to 21); lane 6 is the 
S30Q fraction (25); lane 7 is the S30Q fraction (27); lane 8 is S30Q fraction (32) and lane 9 is S30Q 
fraction (35); and lane 10 is the waste fraction. 
Figure 6 below shows the results for BA subunits. Figure 6A shows the chromato-
gram of the Source 30Q purification at 280 nm absorbance, and Figure 6B at the 
next page shows the SDS gel results of the fractions from the S30Q purification 
step. The peak was located between fractions number 14 and 26. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6A.  Source 30 Q chromatography results for BA subunits: absorbance at 280 nm, and peak is 
between fraction numbers 14 and 26. 
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Figure 6B. SDS–PAGE results from peak fraction of the Source 30Q chromatography of BA subu-
nits: lane 1 is the Low molecular weight (LMW) marker; lane 2 is sucrose sample; lane 3 is 
periplasmic fraction; lane 4 is S30Q fraction (15); lane 5 is the S30Q fraction (18); lane 6 is the 
S30Q fraction (20); lane 7 is the S30Q fraction (32); lane 8 is S30Q fraction (35); lane 9 is the waste 
fraction; and lane10 is the flow throw fraction. 
3.4   Anion-exchange chromatography (Mono Q) results 
Results of Mono Q chromatography are shown in Figure 7 and Figure 8 for BB 
and BA subunits. Figure 7A shows the chromatogram of the Mono Q purification 
at 280 nm absorbance, and Figure 7B shows the SDS gel results of the fractions 
from the Mono Q purification step. Peak was located between fractions number 31 
and 38. 
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Figure 7A MonoQ chromatography results for BB subunits: absorbance at 280 nm and peak is be-
tween fraction numbers 31 and 38. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7B. SDS–PAGE results from peak fraction of the MonoQ chromatography of BB subunits: 
lane 1 is the Low MW marker; lane 2 is periplasmic fraction; lane 3 is MonoQ Fraction 33; lane 4 is 
MQ fraction (35); lane 5 is the MQ fraction (38); and lane 6 is the MQ fraction (42). 
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-BA 
Figure 8 below shows the results for BA subunits. Figure 8A shows the chromato-
gram of the MonoQ purification at 280 nm absorbance, and Figure 8B shows the 
SDS gel results of fractions from the MonoQ purification step and previous S30Q 
peak results. Mono Q Peak was located between fraction numbers 21 and 28.  
 
Figure 8A. MonoQ chromatography results for BA subunits: absorbance at 280 nm and peak is lo-
cated between fraction numbers 21 and 28. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8B.SDS–PAGE results from peak fraction of the MonoQ chromatography of BA subunits: 
lane 1 is the molecular weight marker; lane 2 is periplasmic fraction; lane 3 is S30Q sample; lane 4 is 
MQ fraction (22); lane 5 is the MQ fraction (23); lane 6 is the MQ fraction (26); lane 7 is the MQ 
fraction (27); lane 8 is MQ fraction (32); and lane 9 is the flow through fraction. 
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3.5 Size exclusion chromatography (Gel filtration) 
Results of Gel Filtration are shown in Figure 9 and Figure 10 for BB and BA sub-
units, respectively. 
Figure 9 shows the results for BB subunits. Figure 9A shows the chromatogram 
of the gel filtration (GF) purification at 280 nm absorbance, and Figure 9B, at the 
next page, shows the SDS gel results from gel filtration purification step. GF Peak 
was located between fraction numbers 16 and 21.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9A.Gel Filtration chromatography results for BB subunits: absorbance at 280 nm and peak is 
located between fraction numbers 16 and 21. 
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Figure 9B. SDS–PAGE results from peak fraction of Gel Filtration chromatography of BB subunits:  
lane 1 is the MW marker; lane 2 is periplasmic fraction; lane 3 is the GF fraction (19); and lane 4 is 
the GF f21. 
Figure 10 below shows the results for BA subunits. Figure 10A shows the chroma-
togram of the gel filtration purification at 280 nm absorbance, and Figure 10B, on 
the next page, shows the SDS gel results of fractions from the Gel filtration purifi-
cation step. GF Peak was located between fraction numbers 19 and 24. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10A. Gel Filtration chromatography results for BA subunits: absorbance at 280 nm and peak 
between fraction numbers 19 and 24. 
-BA 
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Figure 10B. SDS–PAGE results from peak fraction of Gel Filtration chromatography of BA subu-
nits: lane1 is the MW marker; lane 2 is periplasmic fraction; lane 3 is S30Q sample; lane 4 is MQ 
sample; lane 5 is the GF fraction (19); lane 6 is the GF fraction (20); lane 7 is the GF fraction (21); 
lane 8 is GF fraction (22); and lane 9 is the GF fraction 24. 
3.6 Results of Circular Dichroism (CD) Spectroscopy  
Both chemical and thermal stability tests were done for the four subunits using 
(GdnHCl) and heat treatment between 30 °C to 90 °C, respectively. Results of the 
chemical and thermal denaturing of the four subunits were shown in Figure 11 and 
Figure 12 respectively. Figure 13 shows the fraction percentage of folded and un-
folded protein states.  
3.6.1 Chemical denaturation of the CssA_dscA subunits. 
Figure 11 and Table 8 on the next page show the chemical denaturation of the four 
subunits. The AA subunits denatured or unfolded around 1M of GdnHCl, while 
the subunit AB unfolded around 2.25 M of GdnHCl. On the other hand, the BB 
subunit was unfolded around 3 M of GdnHCl. Finally, the BA subunit was stable 
for the highest concentration of 4 M Guanidine Hydrochloride. Note that hetero-
polymerization of any of the two subunits, AB and BA gives higher chemical sta-
bility against the GdnHCl denaturation compared to the homo-polymerization, AA 
or BB. These results favour the presence of hetero-polymerization of the subunits, 
which would be used by the ETEC bacteria to form their effective structures. 
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Figure 11. Circular Dichroism (CD) results of chemical denaturing of the four subunits. 
Table 8. Summary of Chemical stability using (GdnHCl) needed for protein denaturation 
Subunit  GdnHCl (M) 
Css6-BA 4 
Css6-BB 3 
Css6-AB 2.25 
Css6-AA 1 
3.6.2 Thermal stability 
Figure 12 in the next page, shows the results of the studied protein subunits which 
were heated from 30 °C to 90 °C in the absence of GdnHCl. Results of thermal 
denaturation showed that the AA subunits started to denature at 53°C, AB started 
at 75°C, BB started at 58°C, and finally, BA started at 71 °C. Here it is noted that 
hetero-polymerization of any two subunits, AB and BA gave higher stability 
against thermal denaturation compared to the homo-polymerization, AA or BB. 
These results favour the presence of hetero-polymerization of these subunits as the 
effective structures to be used by the ETEC Bacteria. The summary of melting 
temperature needed for protein denaturation is presented in Table 9 below. 
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Figure 12. CD results of four subunits. Melting denaturing of AB-AA subunits at 208 nm showed in 
part A at left side. Melting denaturation of BB-BA subunits at 215 nm showed in part B at right side. 
Table 9. Summary of Melting Temperature needed for protein denaturation. 
Subunit  Temp (°C) 
Css6-BA 71° 
Css6-AB 75° 
Css6-BB 58° 
Css6-AA 53° 
3.6.3 Calculated free energy change, ΔG (kJ/mol) 
 Figure 13 on the following page, shows the ellipticity curves plotted over a range 
of temperatures (K) and normalized between 0-1; representing the fraction (%) of 
protein in folded and unfolded states. The calculated free energy change ∆G 
(kJ/mol) is provided at the melting temperature (Tm), and is shown in Table 9 
above, for each of the four subunits. 
 The free energy change is calculated at the melting temperature for the four 
subunits. ΔG was for AA, 0.22 (kJ/mol); for AB, the ΔG was 0.570 (kJ/mol). For 
BB, ΔG was 0.08 (kJ/mol); while for BA, the ΔG was 2.24 (kJ/mol). Table 10 on 
the next page summarises and compares the ΔG results based on thermal 
denaturation curves. Here it is noted that BA was the most stable subunit, then AB 
followed by BB and finally AA subunits. This suggests that hetero-polymerized 
subunits are more heat stable than homo-polymerized ones. 
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Figure 13. Fractions for folded and unfolded percentage of the four subunits, AA, AB, BB and BA as 
function of Temperature (K). Calculated free energy for unfolding at melting temperature is provid-
ed. 
Table 10. Summary free energy change, ΔG (KJ/mol), needed for thermal denaturation at melting 
point (Tm) of each subunit. 
Subunit  ∆G(KJ) 
Css6- BA 2.24 
Css6- AB 0.570 
Css6 -BB 0.080 
Css6-AA 0.220 
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The Donor strand complementation (DSC) theory was successfully implemented 
to study the four candidate fimbrial subunits based on previous project work. 
These four fimbrial subunits (AA, AB, BB and BA) were constructed using PCR, 
then protein expressed and purified using liquid chromatography techniques, after 
that, they have been studied chemically and thermally in a successful manner. 
The protein expressions of the hetero-polymerized subunits (AB and BA) were 
stronger than the homo-polymerized subunits (AA and BB). Previous studies indi-
cated that the expression of subunits (AA) and (BB) is in equal amounts but the 
latter (BB) is more immunogenic than (AA) (Ghosal, Bhowmick et al. 2009). 
These last finding regarding the equal expression of both subunits could strengthen 
our results about the predicted functional unit, favouring model 3 (M3) in our hy-
pothesis as shown in Figure 2 previously. This prediction is favouring the for-
mation of the hetero-polymerization of alternating both subunit A and B together. 
The other results of chemical denaturation, thermal stability and free energy 
change that were summarized in Tables, 8, 9 and 10, respectively, are all generally 
strengthening the possibility of the hetero–polymerization of alternating both sub-
units to be more stable than the homo-polymerization of AA or BB. 
Further studies are needed to get better understanding of the mechanism of 
ETEC attachment to the host intestinal cells. These studies include crystallization, 
solving the 3D structure of the crystals, and studies on a candidate DNA vaccina-
tion strategy. In addition, other studies dealing with potentials treatment methods 
for inhibiting the formation of these colonization factors are needed. 
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Enterotoxigenic Escherichia coli (ETEC) are one of common pathogens causing 
diarrhoea in people worldwide. This bacterium is affecting mainly young children 
under 5 years of old in developing countries, which can lead to their death and be 
regarded as the second most common cause of diarrhoea after retrovirus in chil-
dren. For travellers, it causes the famous disease “traveller’s diarrhoea”. Adult 
visitors and tourists from North America and Europe to endemic areas of develop-
ing countries are often affected with traveller’s diarrhoea caused mainly by ETEC 
and carry back the pathogen to their home lands. 
Regions of rapid population growth especially in suburban regions with poor 
quality water, poor infrastructures facilities and lack of sewage systems will 
increase the risk factors of ETEC infections. The main source for infection with 
ETEC is the faecal-oral route from contaminated food, water and beverages due to 
poor hygienic conditions. 
Clinical Feature  
Most clinical cases of diarrhoea caused by ETEC can occur early after eight hours 
from the infection and last about four days without treatment (self-limited), while 
symptoms vary from mild to severe. The pathophysiology of the ETEC infection 
resembles the disease caused by Vibrio cholera (causes cholera disease) and the 
symptoms are usually identical especially in adult patients. 
Bacteriology and virulence factors  
Enterotoxigenic Escherichia coli (ETEC) belong to the Enterobacteriaceae family, 
which is mostly Gram-negative, non-spore-forming, motile, lactose fermentative 
rod shaped organisms. 
In order to induce the disease, the ETEC strains should attach or colonize the 
small intestine mucosa after being ingested by individuals. This attachment to the 
host enteric epithelial cells is facilitated by the presence of surface antigens called 
colonization factor antigens (CFAs) or coli surface antigens (CSs). These factors 
are mostly immunogenic proteins that bind to receptors on the host intestinal mu-
cosa. 
6 Popular science summary  
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The frequently isolated ETEC strains from patients have an immunogenic sur-
face protein colonization factor CS6. This surface antigen CS6 is helping in adhe-
sion to the host small intestinal epithelium enabling ETEC to produces their two 
main toxins, heat-labile (LT) and/ or heat-stable (ST) enterotoxin.  
Aim of This Study 
This study was conducted as the first step to understand the possible basic struc-
tures of the CS6 gene, which responsible mainly in attachment of ETEC to the 
patient intestinal cells. Revealing the structure and assembly of this CS6 gene will 
help in understanding the pathogenesis, diagnosis and future treatment methods. 
Vaccination as well can be studied and developed as a preventive method against 
ETEC. 
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